- Home
- LICY vs XTNT Comparison
LICY vs XTNT Comparison
Compare LICY & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LICY
- XTNT
- Stock Information
- Founded
- LICY 2016
- XTNT N/A
- Country
- LICY Canada
- XTNT United States
- Employees
- LICY 384
- XTNT N/A
- Industry
- LICY Environmental Services
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LICY Industrials
- XTNT Health Care
- Exchange
- LICY Nasdaq
- XTNT Nasdaq
- Market Cap
- LICY 37.9M
- XTNT 69.3M
- IPO Year
- LICY N/A
- XTNT N/A
- Fundamental
- Price
- LICY $1.07
- XTNT $0.57
- Analyst Decision
- LICY Hold
- XTNT Strong Buy
- Analyst Count
- LICY 2
- XTNT 1
- Target Price
- LICY $4.13
- XTNT $3.00
- AVG Volume (30 Days)
- LICY 2.5M
- XTNT 80.1K
- Earning Date
- LICY 03-14-2025
- XTNT 11-12-2024
- Dividend Yield
- LICY N/A
- XTNT N/A
- EPS Growth
- LICY N/A
- XTNT N/A
- EPS
- LICY N/A
- XTNT N/A
- Revenue
- LICY $27,400,000.00
- XTNT $113,862,000.00
- Revenue This Year
- LICY $61.64
- XTNT $31.27
- Revenue Next Year
- LICY $21.35
- XTNT $13.07
- P/E Ratio
- LICY N/A
- XTNT N/A
- Revenue Growth
- LICY N/A
- XTNT 45.11
- 52 Week Low
- LICY $0.92
- XTNT $0.33
- 52 Week High
- LICY $15.36
- XTNT $1.30
- Technical
- Relative Strength Index (RSI)
- LICY 32.68
- XTNT 68.00
- Support Level
- LICY $0.92
- XTNT $0.49
- Resistance Level
- LICY $1.25
- XTNT $0.55
- Average True Range (ATR)
- LICY 0.26
- XTNT 0.07
- MACD
- LICY -0.09
- XTNT 0.01
- Stochastic Oscillator
- LICY 9.51
- XTNT 68.71
About LICY Li-Cycle Holdings Corp.
Li-Cycle Holdings Corp is a lithium-ion battery resource recovery and lithium-ion battery recycler. The company's proprietary process Spoke and Hub recycling process is designed at its Spokes, to process battery manufacturing scrap and end-of-life batteries to produce black mass and other intermediate products, and at its Hubs, to process black mass to recover raw materials, including but not limited to lithium carbonate, cobalt sulphate, and nickel sulphate.
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.